BioSpace News Archive

Merck’s Keytruda Helps Again: This Time in Triple-Negative Breast Cancer

Merck has announced positive results from its Phase III KEYNOTE-522 study on the use of KEYTRUDA alongside chemotherapy in high-risk early-stage triple-negative breast cancer.

February 10, 2022

·

2 min read

·

Vanessa Doctor, RN

Business

Oxford Professor: Tarnished AstraZeneca Vaccine Rep Probably “Killed Hundreds of Thousands”

As AstraZeneca released its 2021 annual financial report, a BBC documentary suggested that the way scientists and politicians politicized its COVID-19 vaccine may have cost lives.

February 10, 2022

·

3 min read

·

Mark Terry

Policy

BioNTech Reps Accused of Holding Up WHO Africa Vaccine Production

kENUP had called the mRNA vaccine efforts in Africa “doomed to fail” since the project likely infringes on BioNTech and Moderna patents on the vaccine.

February 10, 2022

·

2 min read

·

Hannah Chudleigh

Drug Development

FDA’s ODAC Says Lilly & Innovent Must Run U.S. Trial

The FDA’s Oncologic Drugs Advisory Committee (ODAC) has recommended 14-1 that the two companies conduct a trial applicable to the U.S. population.

February 10, 2022

·

3 min read

·

Mark Terry

Business

Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror

Teva Pharmaceuticals reported solid earnings for the full year of 2021, posting $15.9 billion in revenues alongside gains of $4.1 billion from the fourth quarter alone.

February 10, 2022

·

2 min read

·

Vanessa Doctor, RN

Drug Development

Novartis-Partnered COVID-19 Antiviral Seeks Emergency Use Authorization

The EUA request is based on the Phase II study that showed treatment with ensovibep reduced the viral load from the SARS-CoV-2 virus within eight days of use compared to placebo.

February 10, 2022

·

2 min read

·

Alex Keown

Research Roundup: Vitamin D Deficiency and Severe COVID-19

Recent research supports a link between vitamin D deficiency and severe COVID-19. Here’s a look.

February 10, 2022

·

6 min read

·

Mark Terry

Business

Biotech Stocks Take Hit as Wary Investors Look Elsewhere

The London-based Financial Times reported that 83% of companies listed on stock exchanges over the past two years are now trading well below their initial public offering price.

February 10, 2022

·

3 min read

·

Alex Keown

Policy

COVID Update: Revisiting the Lab-Leak Theory and Under 5 Vaccination

It’s uncertain if the origins of COVID-19 will ever be determined, but the current top theories split about evenly between a lab leak from the Wuhan Institute of Virology and a natural evolution from bats to animals to humans at a Wuhan “wet market.”

February 10, 2022

·

6 min read

·

Mark Terry

Business

Bayer Takes a Leap for Off-the-Shelf NK Cell Therapy

Bayer joined in the $50 million Series A for San Francisco’s Indapta Therapeutics.

February 10, 2022

·

2 min read

·

Kate Goodwin